|Bid||167.00 x 6000|
|Ask||169.85 x 35000|
|Day's Range||176.05 - 177.50|
|52 Week Range||156.50 - 197.15|
|PE Ratio (TTM)||32.05|
|Dividend & Yield||3.61 (1.75%)|
|1y Target Est||N/A|
Half Year 2017 L'Oreal SA Earnings Call
Ulta Beauty Inc (NASDAQ: ULTA )'s nearly 15 percent sell-off over the past month could be the beginning of the stock's longer-term trend, analysts at Oppenheimer said. The firm's Rupesh Parikh downgrades ...
GlaxoSmithKline's new chief executive announced plans on Wednesday to narrow the focus of the group's drug research by ditching more than 30 drug projects to improve returns in its core pharmaceuticals business. Emma Walmsley, who took over in April, said GSK would in future allocate 80 percent of its R&D budget to respiratory and HIV/infectious diseases, along with two other potential areas of oncology and immuno-inflammation.